XML 44 R31.htm IDEA: XBRL DOCUMENT v3.22.0.1
Note 13 - Summary of Stock Options (Tables)
12 Months Ended
Dec. 31, 2021
Notes Tables  
Share-based Payment Arrangement, Option, Activity [Table Text Block]
  

 

Number

of

Shares

  

 

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term (years)

  

 

Aggregate

Intrinsic

Value

 

Options outstanding, January 1, 2021

  986,399  $19.10   8.9  $675 

Options granted

  2,251,000  $2.73         

Options exercised

  -            

Options canceled

  (64,296) $17.85         

Options outstanding, December 31, 2021

  3,173,103  $7.51   9.0  $- 
                 

Vested and exercisable and expected to vest, December 31, 2021

  2,947,472  $7.83   9.0  $- 
                 

Vested and exercisable, December 31, 2021

  774,800  $18.81   8.5  $- 
Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

Range of

Exercise Prices

 

Number

Outstanding

as of

December 31, 2021

  

Weighted

Average

Exercise

Price
  

Weighted

Average

Remaining

Contractual

Term (Years)
  

Number

Exercisable

as of

December 31, 2021
  

Weighted

Average

Exercise

Price
 
                       
$2.28-

$2.96

  2,208,063  $2.73   9.5   259,301  $2.73 
$3.06-

$3.40

  10,000  $3.20   9.2   -  $- 
$4.45-

$4.80

  11,900  $4.72   8.9   3,088  $4.71 
$5.10-

$5.40

  88,000  $5.28   8.8   62,219  $5.34 
$6.90-

$6.90

  5,400  $6.90   8.3   2,364  $6.90 
$8.60-

$8.91

  830,825  $8.69   7.9   433,263  $8.69 
$10.90-

$13.60

  15,500  $12.64   8.2   11,271  $13.00 
$380.00-

$9,920.00

  3,415  $2,873.63   6.2   3,294  $2,911.12 
Total: 

 

  3,173,103  $7.51   9.0   774,800  $18.81 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

Year Ended

December 31,

 
  

2021

  

2020

 
         

Expected term (in years)

  6   5 

Average volatility

  76%  82%

Risk-free interest rate

  0.97%  0.37%

Dividend yield

  0%  0%
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
  

Year Ended

December 31,

 
  

2021

  

2020

 
         

Cost of revenue

 $265  $208 

Research and development

  456   325 

Selling, general and administrative

  3,058   2,118 

Total

 $3,779  $2,651